TC
| |
TANG CAPITAL MANAGEMENT LLC13F | |
TANG CAPITAL MANAGEMENT LLC | |
Last update 2024-11-15 | 154 Stocks (35 new) |
Value $1.40 Bil | Turnover 26 % |
Portfolio Report |
TANG CAPITAL MANAGEMENT LLC Top Holdings of 2024-09-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EOLS | Evolus Inc | 4,847,399 | 78527.860 | 0% | 5.610 | 0% | 7.660 | -39.58% | -9.42% | 633.215 | Drug Manufacturers | |
TARS | Tarsus Pharmaceuticals Inc | 2,254,797 | 74160.270 | 0% | 5.300 | 0% | 5.930 | +48.42% | -4.84% | 2014.177 | Biotechnology | |
AUPH | Aurinia Pharmaceuticals Inc | 7,229,500 | 52992.240 | +160.10% | 3.790 | +2.33% | 5.050 | +15.62% | -10.13% | 1155.457 | Biotechnology | |
VRDN | Viridian Therapeutics Inc | 2,242,925 | 51026.540 | +61.02% | 3.650 | +1.38% | 2.940 | -17.27% | -5.06% | 1441.672 | Biotechnology | |
MIRM | Mirum Pharmaceuticals Inc | 1,287,107 | 50197.170 | 0% | 3.590 | 0% | 2.700 | +7.38% | -0.07% | 1983.549 | Biotechnology | |
KALV | KalVista Pharmaceuticals Inc | 4,321,547 | 50043.510 | +2.43% | 3.570 | +0.08% | 8.780 | -28.57% | -7.32% | 387.931 | Biotechnology | |
ANAB | AnaptysBio Inc | 1,330,879 | 44584.450 | 0% | 3.180 | 0% | 4.370 | -55.59% | +7.33% | 432.392 | Biotechnology | |
IMCR | Immunocore Holdings PLC | 1,105,600 | 34417.330 | +172.58% | 2.460 | +1.56% | 2.210 | -1.59% | +3.05% | 1520.996 | Biotechnology | |
PCVX | Vaxcyte Inc | 300,000 | 34281.000 | 0% | 2.450 | 0% | 0.240 | -27.35% | -0.95% | 10105.531 | Biotechnology | |
BNTX | BioNTech SE | 270,000 | 32067.900 | New Holding | 2.290 | +2.29% | 0.110 | +3.78% | +7.81% | 29452.059 | Biotechnology |
TANG CAPITAL MANAGEMENT LLC's Historical Top Holdings Breakdowns
TANG CAPITAL MANAGEMENT LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2024-03-31 | Sold Out | -8.46% | 58.7 ($58.94) 59.28 | $58.70 | -0.41% | Sold Out | 0 | -1,558,059 | |
MRTX | Mirati Therapeutics Inc | 2023-12-31 | Add | +7.48% | 41.99 ($56.22) 62.38 | $58.70 | 4.41% | Add 765.59% | 1,558,059 | 1,378,059 | |
IMGN | Immunogen Inc | 2024-03-31 | Sold Out | -6.02% | 29.26 ($29.77) 31.23 | $31.23 | 4.90% | Sold Out | 0 | -2,199,137 | |
LIANY | LianBio | 2024-03-31 | Sold Out | -3.87% | 0.31 ($3.78) 4.99 | $0.26 | -93.04% | Sold Out | 0 | -9,366,783 | |
NVO | Novo Nordisk A/S | 2023-06-30 | Sold Out | -3.20% | 77.99 ($81.65) 86.33 | $86.26 | 5.65% | Sold Out | 0 | -135,000 | |
NVO | Novo Nordisk A/S | 2023-03-31 | New Buy | +3.20% | 66.17 ($70.91) 79.57 | $86.26 | 21.65% | New holding | 270,000 | 135,000 | |
EQRX | EQRx Inc | 2023-12-31 | Sold Out | -3.16% | 2.04 ($2.25) 2.47 | $2.34 | 4.00% | Sold Out | 0 | -10,086,110 | |
EQRX | EQRx Inc | 2023-09-30 | New Buy | +3.16% | 1.66 ($2.14) 2.31 | $2.34 | 9.35% | New holding | 10,086,110 | 10,086,110 | |
LIANY | LianBio | 2023-12-31 | Add | +3.13% | 1.33 ($3.44) 4.6 | $0.26 | -92.35% | Add 420.38% | 9,366,783 | 7,566,783 | |
EOLS | Evolus Inc | 2023-03-31 | Add | +3.01% | 7.81 ($9.04) 11.05 | $10.00 | 10.62% | Add 294.99% | 3,197,399 | 2,387,911 |
TANG CAPITAL MANAGEMENT LLC Total Holding History ($B)
TANG CAPITAL MANAGEMENT LLC's Asset Allocation
TANG CAPITAL MANAGEMENT LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
TANG CAPITAL MANAGEMENT LLC's Hypothetical Growth since 2024-09-30
TANG CAPITAL MANAGEMENT LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
TANG CAPITAL MANAGEMENT LLC's Holdings Heat Map
Size field:
TANG CAPITAL MANAGEMENT LLC's Holdings Bubble Chart
TANG CAPITAL MANAGEMENT LLC News
- 1